alto.comHealthcare / Digital HealthFounded: 2015Funding to Date: $670.55MM
Alto Pharmacy is a digital pharmacy focused on delivering prescriptions to patients without delivery fees. As with physical pharmacies, patients are able to chat directly with Alto pharmacists to ask questions about their care across general health, sexual health, heart health, fertility, and more. Alto Pharmacy was founded in 2015 by Jamie Karraker, Mattieu Gamache-Asselin, and Vladimir Blumen and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/25/2023 | Series EEE-1 | $2.58MM | $xx.xx | $799.9MM | What If Ventures | |
Price per Share
$xx.xx
Shares Outstanding
151,690
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
What If Ventures
|
||||||
09/25/2023 | Series CCC-4 | $15.69MM | $xx.xx | $799.9MM | What If Ventures | |
Price per Share
$xx.xx
Shares Outstanding
2,525,760
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
What If Ventures
|
||||||
09/25/2023 | Series FF | $101.74MM | $xx.xx | $799.9MM | What If Ventures | |
Price per Share
$xx.xx
Shares Outstanding
16,560,717
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
What If Ventures
|
||||||
01/27/2022 | Series EEE | $200MM | $xx.xx | $1.51B | Softbank | |
Price per Share
$xx.xx
Shares Outstanding
12,936,611
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Softbank
|
||||||
02/04/2020 | Series DDD | $246.4MM | $xx.xx | $751.58MM | Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Softbank, Zola Global | |
Price per Share
$xx.xx
Shares Outstanding
25,130,023
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Softbank, Zola Global
|
||||||
06/19/2019 | Series CCC | $30MM | $xx.xx | $261.15MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,830,751
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/05/2018 | Series CCC-2 | $9.38MM | $xx.xx | $164.84MM | Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital | |
Price per Share
$xx.xx
Shares Outstanding
2,316,805
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital
|
||||||
12/05/2018 | Series CCC-1 | $41.03MM | $xx.xx | $164.84MM | Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital | |
Price per Share
$xx.xx
Shares Outstanding
8,616,165
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital
|
||||||
06/12/2017 | Series BBB | $17.15MM | $xx.xx | $55.98MM | Craig Sherman, Daniel Kan, Greenoaks Capital, Jackson Square Ventures, Justin Kan, Rahul Mehta | |
Price per Share
$xx.xx
Shares Outstanding
5,902,610
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Craig Sherman, Daniel Kan, Greenoaks Capital, Jackson Square Ventures, Justin Kan, Rahul Mehta
|
||||||
06/10/2016 | Series AAA-1 | $649,991.76 | $xx.xx | $17.25MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
774,722
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/10/2016 | Series AAA | $5.95MM | $xx.xx | $17.25MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,879,912
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|